NIDA offers Genotyping to Substance Abuse Disorder Investigators
Notice Number:

Key Dates

Release Date:
May 12, 2020

Related Announcements

Issued by

National Institute on Drug Abuse (NIDA)


The National Institute on Drug Abuse is offering free genotyping for existing extracted DNA samples from people suffering from substance abuse disorders, who have consented for addiction/and or genetic studies. The proposed samples for genotyping offered by investigators will be selected by administrative review by NIDA staff. The NIDA Center for Genetic Studies at RUDCR will do all the genotyping of samples submitted. These data once cleaned will be submitted into dbGaP, where they will be stored for a 6 month period prior to public data release per the NIH Genomic Data Sharing Policy. During that time submitting investigators will have the chance to analyze their own data. Once the data are released to the public there are no other time restrictions or embargo periods.

Submitting a request for genotyping of extracted DNA samples

This Notice requests investigators who have relevant samples to submit a description of the number of samples, the phenotypes collected, and a description of the quality of the DNA samples. Please

submit requests no later than September 14, 2020.

Please include the following information with youra request for genotyping:

  • Descriptive title of proposed research.
  • Name, address, and telephone number of the PD(s)/PI(s)
  • Participating Institutions
  • DNA or tissue or fluid to be used for genotyping. 
  • Number of samples to be genotyped
  • Demographics
  • NIH PhenX Substance Abuse and Addiction measures
  • Behavioral/Psychosocial indicators and
  • Nicotine dependence measures and/or
  • Marijuana/Cannabis dependence measures and/or
  • Cocaine dependence measures and/or
  • Opiate dependence measures and/or
  • Multi-drug dependence measures and/or

The decision to accept samples for genotyping will be made administratively by NIDA Staff. If NIDA accepts the samples, genotyping will be offered free of charge to the submitting investigator.


Please direct all inquiries to:

Jonathan D. Pollock, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1309

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices